$AVDL
AVADEL PHARMACEUTICALS PLC Stock $avdl

$avdl Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-Q Financial Statement

#000101247717000051 Filed on November 09, 2017

Income Statement

Concept	2017 Q4	2017 Q3	2016 Q3
Revenue	$34.75M	$39.68M	$32.09M
YoY Change	-19.35%	23.65%	-32.18%
Cost Of Revenue	$4.050M	$3.790M	$2.844M
YoY Change	56.37%	33.26%	36.27%
Gross Profit	$30.70M	$35.89M	$29.24M
YoY Change	-24.18%	22.71%	-35.34%
Gross Profit Margin	88.35%	90.45%	91.14%
Selling, General & Admin	$23.06M	$11.56M	$12.74M
YoY Change	115.72%	-9.24%	178.9%
% of Gross Profit	75.11%	32.22%	43.57%
Research & Development	$11.33M	$8.095M	$8.143M
YoY Change	-15.95%	-0.59%	12.77%
% of Gross Profit	36.91%	22.56%	27.85%
Depreciation & Amortization	$2.220M	$1.050M	$3.880M
YoY Change	-24.23%	-72.94%	18.65%
% of Gross Profit	7.23%	2.93%	13.27%
Operating Expenses	$36.34M	$19.66M	$20.88M
YoY Change	33.95%	-5.87%	77.14%
Operating Profit	-$5.640M	$26.12M	-$16.19M
YoY Change	-142.22%	-261.32%	11.76%
Interest Expense	-$850.0K	-$400.0K	-$840.0K
YoY Change	-197.7%	-52.38%	-87.04%
% of Operating Profit		-1.53%
Other Income/Expense, Net	-$760.0K	$768.0K	-$1.828M
YoY Change	-642.86%	-142.01%	-1014.0%
Pretax Income	-$5.690M	$27.60M	-$16.54M
YoY Change	-131.47%	-266.84%	-20.36%
Income Tax	$6.070M	$5.921M	$3.451M
% Of Pretax Income		21.45%
Net Earnings	-$8.250M	$21.68M	-$19.99M
YoY Change	-274.42%	-208.43%	-28.78%
Net Earnings / Revenue	-23.74%	54.64%	-62.31%
Basic Earnings Per Share		$0.54	-$0.48
Diluted Earnings Per Share	-$209.7K	$0.52	-$0.48
COMMON SHARES
Basic Shares Outstanding	39.76M shares	40.06M shares	41.24M shares
Diluted Shares Outstanding		41.34M shares	41.24M shares

Balance Sheet

Concept	2017 Q4	2017 Q3	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$94.10M	$115.6M	$149.7M
YoY Change	-38.98%	-22.78%
Cash & Equivalents	$16.56M	$37.45M	$18.78M
Short-Term Investments	$77.50M	$78.20M	$130.9M
Other Short-Term Assets	$128.0K	$1.700M	$6.100M
YoY Change	-97.28%	-72.13%
Inventory	$6.157M	$5.870M	$3.909M
Prepaid Expenses	$7.106M	$1.002M	$4.456M
Receivables	$14.79M	$24.08M	$15.40M
Other Receivables	$1.700M	$1.600M	$2.800M
Total Short-Term Assets	$124.0M	$148.9M	$177.9M
YoY Change	-31.58%	-16.26%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.001M	$3.180M	$3.186M
YoY Change	-9.61%	-0.19%
Goodwill	$18.49M	$18.49M	$19.13M
YoY Change	0.0%	-3.36%
Intangibles	$92.29M	$94.26M	$25.51M
YoY Change	304.12%	269.52%
Long-Term Investments	$3.400M
YoY Change
Other Assets	$10.25M	$9.020M	$6.820M
YoY Change	36.09%	32.26%
Total Long-Term Assets	$129.3M	$128.5M	$70.13M
YoY Change	101.1%	83.22%
TOTAL ASSETS
Total Short-Term Assets	$124.0M	$148.9M	$177.9M
Total Long-Term Assets	$129.3M	$128.5M	$70.13M
Total Assets	$253.3M	$277.4M	$248.0M
YoY Change	3.18%	11.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.477M	$8.564M	$8.966M
YoY Change	5.24%	-4.48%
Accrued Expenses	$50.93M	$48.00M	$13.03M
YoY Change	195.7%	268.3%
Deferred Revenue	$2.007M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$111.0K	$301.0K	$286.0K
YoY Change	-58.58%	5.24%
Total Short-Term Liabilities	$86.54M	$97.31M	$59.19M
YoY Change	38.64%	64.41%
LONG-TERM LIABILITIES
Long-Term Debt	$156.0K	$614.0K	$734.0K
YoY Change	-71.48%	-16.35%
Other Long-Term Liabilities	$7.084M	$6.911M	$4.307M
YoY Change	34.29%	60.46%
Total Long-Term Liabilities	$7.240M	$7.525M	$5.041M
YoY Change	24.36%	49.28%
TOTAL LIABILITIES
Total Short-Term Liabilities	$86.54M	$97.31M	$59.19M
Total Long-Term Liabilities	$7.240M	$7.525M	$5.041M
Total Liabilities	$167.7M	$181.0M	$211.2M
YoY Change	-17.56%	-14.3%
SHAREHOLDERS EQUITY
Retained Earnings	-$262.7M	-$254.4M	-$324.5M
YoY Change	-17.86%	-21.6%
Common Stock	$393.9M	$391.8M	$381.1M
YoY Change	2.19%	2.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$22.36M	$17.51M
YoY Change
Treasury Stock Shares	5.407M shares	1.673M shares
Shareholders Equity	$85.58M	$96.46M	$36.83M
YoY Change
Total Liabilities & Shareholders Equity	$253.3M	$277.4M	$248.0M
YoY Change	3.18%	11.87%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2016 Q3
OPERATING ACTIVITIES
Net Income	-$8.250M	$21.68M	-$19.99M
YoY Change	-274.42%	-208.43%	-28.78%
Depreciation, Depletion And Amortization	$2.220M	$1.050M	$3.880M
YoY Change	-24.23%	-72.94%	18.65%
Cash From Operating Activities	-$13.82M	-$3.060M	-$4.760M
YoY Change	-278.55%	-35.71%	-125.59%
INVESTING ACTIVITIES
Capital Expenditures	-$1.030M	-$52.35M	-$240.0K
YoY Change	415.0%	21712.5%	-42.86%
Acquisitions
YoY Change
Other Investing Activities	$490.0K	$53.43M	$260.0K
YoY Change	-96.41%	20450.0%	-102.14%
Cash From Investing Activities	-$530.0K	$1.070M	$20.00K
YoY Change	-103.94%	5250.0%	-100.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-6.030M	-3.930M	-620.0K
YoY Change	-10150.0%	533.87%	-88.48%
NET CHANGE
Cash From Operating Activities	-13.82M	-3.060M	-4.760M
Cash From Investing Activities	-530.0K	1.070M	20.00K
Cash From Financing Activities	-6.030M	-3.930M	-620.0K
Net Change In Cash	-20.38M	-5.920M	-5.360M
YoY Change	-195.86%	10.45%	-924.62%
FREE CASH FLOW
Cash From Operating Activities	-$13.82M	-$3.060M	-$4.760M
Capital Expenditures	-$1.030M	-$52.35M	-$240.0K
Free Cash Flow	-$12.79M	$49.29M	-$4.520M
YoY Change	-261.08%	-1190.49%	-123.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q4	avdl	Accrued Contract Manufacturing Organization Liabilities AccruedContractManufacturingOrganizationLiabilities	936000	USD
CY2017Q3	avdl	Accrued Contract Manufacturing Organization Liabilities AccruedContractManufacturingOrganizationLiabilities	2380000	USD
CY2016Q4	avdl	Accrued Contract Research Organization AccruedContractResearchOrganization	1764000	USD
CY2017Q3	avdl	Accrued Contract Research Organization AccruedContractResearchOrganization	1472000	USD
CY2016Q4	avdl	Accrued Expensefor Paymentof Intangible Assets Current AccruedExpenseforPaymentofIntangibleAssetsCurrent	0	USD
CY2017Q3	avdl	Accrued Expensefor Paymentof Intangible Assets Current AccruedExpenseforPaymentofIntangibleAssetsCurrent	20000000	USD
CY2016Q4	avdl	Accrued Social Charges AccruedSocialCharges	794000	USD
CY2017Q3	avdl	Accrued Social Charges AccruedSocialCharges	827000	USD
CY2016Q4	avdl	Accrued Trade Discounts And Rebates AccruedTradeDiscountsAndRebates	7981000	USD
CY2017Q3	avdl	Accrued Trade Discounts And Rebates AccruedTradeDiscountsAndRebates	13453000	USD
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	avdl	Acquisition Related Contingent Consideration Remeasurement AcquisitionRelatedContingentConsiderationRemeasurement	52989000	USD
	avdl	Acquisition Related Contingent Consideration Remeasurement AcquisitionRelatedContingentConsiderationRemeasurement	-30107000	USD
CY2017Q3	avdl	Research And Development Tax Credit Receivable Non Current ResearchAndDevelopmentTaxCreditReceivableNonCurrent	3547000	USD
	avdl	Restructuring Charges Before Gain Loss Dueto Curtailment RestructuringChargesBeforeGainLossDuetoCurtailment	3722000	USD
CY2016Q4	avdl	Advance To Suppliers And Other Current Assets AdvanceToSuppliersAndOtherCurrentAssets	1265000	USD
CY2017Q3	avdl	Advance To Suppliers And Other Current Assets AdvanceToSuppliersAndOtherCurrentAssets	726000	USD
CY2016Q4	avdl	Authorized Share Capital AuthorizedShareCapital	5500000	USD
CY2017Q3	avdl	Business Combination Financing Related Costs BusinessCombinationFinancingRelatedCosts	-768000	USD
	avdl	Business Combination Financing Related Costs BusinessCombinationFinancingRelatedCosts	-2988000	USD
	avdl	Business Combinations Additions Made BusinessCombinationsAdditionsMade	22695000	USD
CY2017Q1	avdl	Distributable Reserves Increase Decrease Adjustment DistributableReservesIncreaseDecreaseAdjustment	317254000	USD
	avdl	Earn Out Payment EarnOutPayment	6834000	USD
	avdl	Earn Out Payment EarnOutPayment	961000	USD
	avdl	Earn Out Payment In Excess Of Acquisition Date Fair Value EarnOutPaymentInExcessOfAcquisitionDateFairValue	14486000	USD
	avdl	Earn Out Payment In Excess Of Acquisition Date Fair Value EarnOutPaymentInExcessOfAcquisitionDateFairValue	24729000	USD
CY2016Q3	avdl	Effective Income Tax Rate Reconciliation Nondeductible Expense Changein Fair Value Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeinFairValueAmount	6436000	USD
	avdl	Effective Income Tax Rate Reconciliation Nondeductible Expense Changein Fair Value Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeinFairValueAmount	17236000	USD
CY2017Q3	avdl	Effective Income Tax Rate Reconciliation Nondeductible Expense Changein Fair Value Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeinFairValueAmount	-3521000	USD
	avdl	Effective Income Tax Rate Reconciliation Nondeductible Expense Changein Fair Value Amount EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeinFairValueAmount	-10751000	USD
CY2016Q3	avdl	Effective Income Tax Rate Reconciliation Nondeductible Expense Changein Fair Value Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeinFairValuePercent	-0.389
	avdl	Effective Income Tax Rate Reconciliation Nondeductible Expense Changein Fair Value Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeinFairValuePercent	-0.620
CY2017Q3	avdl	Effective Income Tax Rate Reconciliation Nondeductible Expense Changein Fair Value Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeinFairValuePercent	-0.128
	avdl	Effective Income Tax Rate Reconciliation Nondeductible Expense Changein Fair Value Percent EffectiveIncomeTaxRateReconciliationNondeductibleExpenseChangeinFairValuePercent	-0.109
	avdl	Financing Related Contingent Consideration Remeasurement FinancingRelatedContingentConsiderationRemeasurement	6135000	USD
	avdl	Financing Related Contingent Consideration Remeasurement FinancingRelatedContingentConsiderationRemeasurement	-2988000	USD
	avdl	Grants Recognized In Other Income And Income From Operations GrantsRecognizedInOtherIncomeAndIncomeFromOperations	70000	USD
	avdl	Grants Recognized In Other Income And Income From Operations GrantsRecognizedInOtherIncomeAndIncomeFromOperations	0	USD
	avdl	Increase Decrease In Research And Development Tax Credit Receivable IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable	1794000	USD
	avdl	Increase Decrease In Research And Development Tax Credit Receivable IncreaseDecreaseInResearchAndDevelopmentTaxCreditReceivable	1576000	USD
CY2016Q3	avdl	License And Research Revenue LicenseAndResearchRevenue	747000	USD
	avdl	License And Research Revenue LicenseAndResearchRevenue	2303000	USD
CY2017Q3	avdl	License And Research Revenue LicenseAndResearchRevenue	528000	USD
	avdl	License And Research Revenue LicenseAndResearchRevenue	484000	USD
CY2016Q4	avdl	Other Noncurrent Receivables OtherNoncurrentReceivables	99000	USD
CY2017Q3	avdl	Other Noncurrent Receivables OtherNoncurrentReceivables	1910000	USD
CY2016Q4	avdl	Provision For Retirement Indemnity Noncurrent ProvisionForRetirementIndemnityNoncurrent	2431000	USD
CY2017Q3	avdl	Provision For Retirement Indemnity Noncurrent ProvisionForRetirementIndemnityNoncurrent	2137000	USD
CY2016Q4	avdl	Research And Development Tax Credit Receivable Non Current ResearchAndDevelopmentTaxCreditReceivableNonCurrent	1775000	USD
	avdl	Royalty Payments For Related Party Financing Related Contingent Consideration RoyaltyPaymentsForRelatedPartyFinancingRelatedContingentConsideration	1117000	USD
	avdl	Royalty Payments For Related Party Financing Related Contingent Consideration RoyaltyPaymentsForRelatedPartyFinancingRelatedContingentConsideration	0	USD
CY2016Q3	avdl	Sales Revenue Goods And Services Net SalesRevenueGoodsAndServicesNet	31340000	USD
	avdl	Sales Revenue Goods And Services Net SalesRevenueGoodsAndServicesNet	104858000	USD
CY2017Q3	avdl	Sales Revenue Goods And Services Net SalesRevenueGoodsAndServicesNet	39147000	USD
	avdl	Sales Revenue Goods And Services Net SalesRevenueGoodsAndServicesNet	138009000	USD
CY2017Q1	avdl	Share Premium Increase Decrease Adjustment SharePremiumIncreaseDecreaseAdjustment	-317254000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	4228000	USD
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001012477
CY2017Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	39762209	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	AVADEL PHARMACEUTICALS PLC
	dei	Trading Symbol TradingSymbol	AVDL
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7105000	USD
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	8564000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17839000	USD
CY2017Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	24080000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	17222000	USD
CY2017Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	47997000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-23565000	USD
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-23421000	USD
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P13Y
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	385020000	USD
CY2017Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	391416000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6019000	USD
CY2016Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3702000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10918000	USD
CY2017Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	564000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1692000	USD
CY2016Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6860000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6860000	shares
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5008000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5086000	shares
CY2016Q4	us-gaap	Assets Assets	245482000	USD
CY2017Q3	us-gaap	Assets Assets	277427000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	181186000	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	148933000	USD
CY2016Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	114980000	USD
CY2017Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	78161000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	1234000	USD
CY2017Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	132000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1472000	USD
CY2017Q3	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	236000	USD
CY2016Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	115218000	USD
CY2017Q3	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	78265000	USD
CY2016Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	635000	USD
	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	709000	USD
CY2017Q3	us-gaap	Available For Sale Securities Gross Realized Gains AvailableForSaleSecuritiesGrossRealizedGains	2978000	USD
CY2016Q3	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	756000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	1430000	USD
CY2017Q3	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	2432000	USD
	us-gaap	Available For Sale Securities Gross Realized Losses AvailableForSaleSecuritiesGrossRealizedLosses	3755000	USD
CY2017Q3	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	3111000	USD
CY2016Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	20848000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	52989000	USD
CY2017Q3	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	-9906000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	-30107000	USD
CY2015Q4	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	122693000	USD
CY2016Q3	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	180285000	USD
CY2016Q4	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	169347000	USD
CY2017Q2	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	127459000	USD
CY2017Q3	us-gaap	Business Combination Liabilities Arising From Contingencies Amount Recognized BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized	107117000	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	628000	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65064000	USD
CY2016Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	18780000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39215000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37449000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-46284000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1766000	USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.122
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41371000	shares
CY2017Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41435000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41371000	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41435000	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	414000	USD
CY2017Q3	us-gaap	Common Stock Value CommonStockValue	414000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20832000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-43041000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	20938000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	76660000	USD
CY2017Q3	us-gaap	Contractual Obligation ContractualObligation	21761000	USD
CY2017Q3	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	3704000	USD
CY2017Q3	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	3704000	USD
CY2017Q3	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	3704000	USD
CY2017Q3	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	3241000	USD
CY2017Q3	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	3704000	USD
CY2017Q3	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	3704000	USD
CY2016Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2844000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10657000	USD
CY2017Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3790000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	12253000	USD
CY2016Q3	us-gaap	Costs And Expenses CostsAndExpenses	48277000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	129190000	USD
CY2017Q3	us-gaap	Costs And Expenses CostsAndExpenses	13557000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	44908000	USD
CY2017Q3	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-11156000	USD
CY2016Q4	us-gaap	Customer Refund Liability Noncurrent CustomerRefundLiabilityNoncurrent	905000	USD
	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.205
CY2017Q3	us-gaap	Customer Refund Liability Noncurrent CustomerRefundLiabilityNoncurrent	1883000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2223000	USD
CY2017Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1927000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	10342000	USD
CY2017Q3	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	0	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	7432000	USD
CY2017Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	7110000	USD
CY2017Q3	us-gaap	Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments	549000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11555000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2664000	USD
CY2016Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	34177000	USD
CY2017Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	40615000	USD
CY2017Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	30986000	USD
CY2016Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	135170000	USD
CY2017Q2	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	86844000	USD
CY2017Q3	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	76131000	USD
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.48
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.12
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.54
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.87
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.48
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.12
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.81
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	656000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	215000	USD
CY2016Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.208
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.655
CY2017Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.214
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.223
CY2016Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.333
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.333
CY2017Q3	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.125
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.125
CY2016Q3	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.020
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.153
CY2017Q3	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.016
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.005
CY2016Q3	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.036
	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.133
CY2017Q3	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.249
CY2016Q3	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.096
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.082
CY2017Q3	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.016
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Other EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther	-0.003
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10124000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11816000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	804000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7594000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6240000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	7882000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	7882000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	3664000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	7067000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	7882000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	32961000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	106072000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	22837000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	94256000	USD
CY2016Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1249000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-12000	USD
CY2017Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-133000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-127000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-110000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2016Q4	us-gaap	Goodwill Goodwill	18491000	USD
CY2017Q3	us-gaap	Goodwill Goodwill	18491000	USD
CY2016Q4	us-gaap	Goodwill Gross GoodwillGross	18491000	USD
CY2017Q3	us-gaap	Goodwill Gross GoodwillGross	18491000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-16543000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-27798000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	27600000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	98346000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3451000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18212000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5921000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	21830000	USD
CY2016Q3	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	339000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	4252000	USD
CY2017Q3	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-438000	USD
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	476000	USD
CY2016Q3	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	591000	USD
	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	3706000	USD
CY2017Q3	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	6861000	USD
	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	20120000	USD
CY2016Q3	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-5509000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-9257000	USD
CY2017Q3	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	3449000	USD
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	12294000	USD
CY2016Q3	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	1594000	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	2275000	USD
CY2017Q3	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	-430000	USD
	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	-309000	USD
CY2016Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	451000	USD
CY2017Q3	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	596000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1291000	USD
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	550000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	5826000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2700000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	9324000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-2198000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-283000	USD
	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-5680000	USD
	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	322000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2080000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2612000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	-2032000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets And Liabilities Net IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet	517000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-671000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1924000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	22837000	USD
CY2017Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	94256000	USD
CY2016Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	264000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	702000	USD
CY2017Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	263000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	789000	USD
CY2016Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2429000	USD
CY2017Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4605000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	3258000	USD
CY2017Q3	us-gaap	Inventory Net InventoryNet	5870000	USD
CY2016Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	829000	USD
CY2017Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	1265000	USD
CY2016Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3223000	USD
CY2017Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	2039000	USD
CY2016Q3	us-gaap	Investment Income Net InvestmentIncomeNet	490000	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	1080000	USD
CY2017Q3	us-gaap	Investment Income Net InvestmentIncomeNet	1110000	USD
	us-gaap	Investment Income Net InvestmentIncomeNet	2689000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	203413000	USD
CY2017Q3	us-gaap	Liabilities Liabilities	180964000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	245482000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	277427000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	62421000	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	97308000	USD
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	59124000	USD
	us-gaap	Liabilities Fair Value Adjustment LiabilitiesFairValueAdjustment	-33095000	USD
CY2016Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	268000	USD
CY2017Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	301000	USD
CY2016Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	547000	USD
CY2017Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	614000	USD
CY2016Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	114980000	USD
CY2017Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	78161000	USD
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-666000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8012000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17292000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-50088000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15167000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11160000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	30478000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-19994000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-46010000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	21679000	USD
	us-gaap	Net Income Loss NetIncomeLoss	76516000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-16190000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-22029000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	26118000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	93585000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	2456000	USD
CY2017Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4483000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7531000	USD
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9020000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1567000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	3927000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-229000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	18000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-838000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2969000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-741000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	144000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	152000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-49000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	92000	USD
	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0	USD
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-2405000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-958000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-512000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	126000	USD
CY2016Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	152000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-49000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	92000	USD
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	226000	USD
CY2017Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	507000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5275000	USD
CY2017Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6911000	USD
CY2016Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	374000	USD
CY2017Q3	us-gaap	Other Long Term Debt OtherLongTermDebt	435000	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1828000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6135000	USD
CY2017Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	768000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2988000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	16707000	USD
	us-gaap	Payments For Restructuring PaymentsForRestructuring	2164000	USD
	us-gaap	Payments For Royalties PaymentsForRoyalties	1790000	USD
	us-gaap	Payments For Royalties PaymentsForRoyalties	3446000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	24227000	USD
CY2017Q3	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	9668000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	29135000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	52139000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	96199000	USD
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	115893000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1000000	USD
CY2017Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	533000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2017Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5894000	USD
CY2017Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3373000	USD
CY2016Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3442000	USD
CY2017Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1002000	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	USD
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	376000	USD
	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	-61000	USD
	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	0	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	46483000	USD
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	153398000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3320000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3180000	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8143000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21135000	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8095000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22093000	USD
CY2016Q3	us-gaap	Restructuring Charges RestructuringCharges	0	USD
	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2017Q3	us-gaap	Restructuring Charges RestructuringCharges	-549000	USD
	us-gaap	Restructuring Charges RestructuringCharges	3173000	USD
CY2016Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	USD
CY2017Q3	us-gaap	Restructuring Reserve RestructuringReserve	1926000	USD
CY2016Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	0	USD
CY2017Q3	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	1926000	USD
	us-gaap	Restructuring Reserve Translation Adjustment RestructuringReserveTranslationAdjustment	-368000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-319800000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-254440000	USD
CY2016Q3	us-gaap	Sales Revenue Net SalesRevenueNet	32087000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	107161000	USD
CY2017Q3	us-gaap	Sales Revenue Net SalesRevenueNet	39675000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	138493000	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	12740000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	33491000	USD
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	11563000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	35804000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	10541000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	6019000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	377000	USD
CY2017Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	25000000	USD
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	1673000	shares
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	17506000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	42069000	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	96463000	USD
CY2016Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1200000	USD
CY2017Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	7026000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2017Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	1673000	shares
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	0	USD
CY2017Q3	us-gaap	Treasury Stock Value TreasuryStockValue	17506000	USD
	us-gaap	Unrealized Gain Loss On Securities UnrealizedGainLossOnSecurities	-12000	USD
	us-gaap	Unrealized Gain Loss On Securities UnrealizedGainLossOnSecurities	-127000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	1565000	USD
CY2017Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2456000	USD
CY2016Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	736000	USD
CY2017Q3	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	1049000	USD
CY2016Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2017Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1278000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	1355000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41241000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41241000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41339000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	42194000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41241000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	41241000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40061000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40839000	shares
CY2016Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	3291000	USD
CY2017Q3	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	3456000	USD

Files In Submission

Name	View Source	Status
0001012477-17-000051-index-headers.html	Edgar Link	pending
0001012477-17-000051-index.html	Edgar Link	pending
0001012477-17-000051.txt	Edgar Link	pending
0001012477-17-000051-xbrl.zip	Edgar Link	pending
avdl-20170930.xml	Edgar Link	completed
avdl-20170930.xsd	Edgar Link	pending
avdl-20170930_cal.xml	Edgar Link	unprocessable
avdl-20170930_def.xml	Edgar Link	unprocessable
avdl-20170930_lab.xml	Edgar Link	unprocessable
avdl-20170930_pre.xml	Edgar Link	unprocessable
avdl2017q3.htm	Edgar Link	pending
exhibit101employmentagreem.htm	Edgar Link	pending
exhibit102employmentagreem.htm	Edgar Link	pending
exhibit103employmentagreem.htm	Edgar Link	pending
exhibit104employmentagreem.htm	Edgar Link	pending
exhibit105employmentagreem.htm	Edgar Link	pending
exhibit106exclusivityagree.htm	Edgar Link	pending
exhibit107licenseagreement.htm	Edgar Link	pending
exhibit108amanufacturingag.htm	Edgar Link	pending
exhibit108bassignmentagree.htm	Edgar Link	pending
exhibit109mastermsa.htm	Edgar Link	pending
exhibit311q32017.htm	Edgar Link	pending
exhibit312q32017.htm	Edgar Link	pending
exhibit321q32017.htm	Edgar Link	pending
exhibit322q32017.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
mastermanufacturingse_image1.gif	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AVDL
AVADEL PHARMACEUTICALS PLC Stock $avdl

2017 Q4 Form 10-Q Financial Statement

#000101247717000051 Filed on November 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVDL AVADEL PHARMACEUTICALS PLC Stock $avdl

2017 Q4 Form 10-Q Financial Statement

#000101247717000051 Filed on November 09, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVDL
AVADEL PHARMACEUTICALS PLC Stock $avdl